Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer

NCT05647109 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 244

Last updated 2025-05-04

No results posted yet for this study

Summary

To construct a prediction model of progesterone sensitivity in patients with endometrial cancer treated with fertility preservation

Conditions

  • Endometrial Carcinoma Stage I
  • Atypical Endometrial Hyperplasia

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Peking University

    collaborator OTHER
  • Beihang University

    collaborator OTHER
  • Peking University People's Hospital

    lead OTHER

Eligibility

Min Age
17 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2025-08-31
Completion
2025-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05647109 on ClinicalTrials.gov